atractylenolide iii has been researched along with Liver Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Gong, L; Li, J; Li, N; Li, X; Liu, L; Luo, H; Sheng, L; Zhang, Q | 1 |
1 other study(ies) available for atractylenolide iii and Liver Neoplasms
| Article | Year |
|---|---|
Atractylenolide III predisposes miR-195-5p/FGFR1 signaling axis to exert tumor-suppressive functions in liver cancer.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Lactones; Liver Neoplasms; MicroRNAs; Receptor, Fibroblast Growth Factor, Type 1; Sesquiterpenes | 2021 |